Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
Sign Up to like & getrecommendations! Published in 2021 at "Obesity Medicine"
DOI: 10.1016/j.obmed.2020.100312
Abstract: COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those… read more here.
Keywords: treatment; glp agonists; friend foe; foe ace2 ... See more keywords